Future Medicine Co., Ltd. (XKON:341170)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,170.00
+5.00 (0.23%)
At close: Jul 11, 2025
-21.09%
Market Cap 20.13B
Revenue (ttm) 1.00B
Net Income (ttm) -13.37B
Shares Out 9.28M
EPS (ttm) -1,637.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,528
Average Volume 4,492
Open 2,080.00
Previous Close 2,165.00
Day's Range 2,000.00 - 2,190.00
52-Week Range 680.00 - 3,400.00
Beta 0.15
RSI 61.95
Earnings Date n/a

About Future Medicine

Future Medicine Co., Ltd. operates as a drug development company worldwide. It develops drugs for use in the treatment of fibrosis and inflammation in non-alcoholic steatohepatitis, chronic kidney disease, glaucoma, and primary biliary cirrhosis; colorectal, prostate, and lung cancer; and COVID-19 and rheumatoid arthritis/atopy. The company was founded in 2015 and is based in Seongnam, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 26
Stock Exchange Korea New Exchange
Ticker Symbol 341170
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.